0001453814-18-000120.txt : 20180906 0001453814-18-000120.hdr.sgml : 20180906 20180906164547 ACCESSION NUMBER: 0001453814-18-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180904 FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bergmann Rouven CENTRAL INDEX KEY: 0001641826 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34387 FILM NUMBER: 181058010 MAIL ADDRESS: STREET 1: C/O MEDIDATA SOLUTIONS, INC. STREET 2: 350 HUDSON STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medidata Solutions, Inc. CENTRAL INDEX KEY: 0001453814 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 522319066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 HUDSON ST., 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212.918.1800 MAIL ADDRESS: STREET 1: 350 HUDSON ST., 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 wf-form4_153626673081688.xml FORM 4 X0306 4 2018-09-04 0 0001453814 Medidata Solutions, Inc. MDSO 0001641826 Bergmann Rouven C/O MEDIDATA SOLUTIONS, INC. 350 HUDSON STREET, 9TH FLOOR NEW YORK NY 10014 0 1 0 0 Chief Financial Officer Common Stock 2018-09-04 4 M 0 20000 53.29 A 98862 D Common Stock 2018-09-04 4 S 0 20000 84.24 D 78862 D Stock Option (right to buy) 53.29 2018-09-04 4 M 0 20000 0 A 2025-05-13 Common Stock 20000.0 37643 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Such transaction was executed in multiple trades at prices ranging from $83.91 to $84.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested as to 25% of the shares on May 13, 2016 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months. /s/ Michael I. Otner, Attorney-in-Fact 2018-09-06